PT99038A - Processo para a preparacao de novos derivados heterociclicos do imidazol e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de novos derivados heterociclicos do imidazol e de composicoes farmaceuticas que os contem Download PDF

Info

Publication number
PT99038A
PT99038A PT99038A PT9903891A PT99038A PT 99038 A PT99038 A PT 99038A PT 99038 A PT99038 A PT 99038A PT 9903891 A PT9903891 A PT 9903891A PT 99038 A PT99038 A PT 99038A
Authority
PT
Portugal
Prior art keywords
methyl
imidazo
pyridine
nmr
pyrrolyl
Prior art date
Application number
PT99038A
Other languages
English (en)
Portuguese (pt)
Inventor
Teruo Oku
Hiroyuki Setoi
Hiroshi Kayakiri
Takayuki Inoue
Akio Kuroda
Sigeki Satoh
Hirokazu Tanaka
Yuki Saitoh
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909020838A external-priority patent/GB9020838D0/en
Priority claimed from GB909023467A external-priority patent/GB9023467D0/en
Priority claimed from GB909028216A external-priority patent/GB9028216D0/en
Priority claimed from GB919103874A external-priority patent/GB9103874D0/en
Priority claimed from GB919106956A external-priority patent/GB9106956D0/en
Priority claimed from GB919107231A external-priority patent/GB9107231D0/en
Priority claimed from GB919112803A external-priority patent/GB9112803D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of PT99038A publication Critical patent/PT99038A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT99038A 1990-09-25 1991-09-24 Processo para a preparacao de novos derivados heterociclicos do imidazol e de composicoes farmaceuticas que os contem PT99038A (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB909020838A GB9020838D0 (en) 1990-09-25 1990-09-25 Condensed imidazole derivatives and process for preparation thereof
GB909023467A GB9023467D0 (en) 1990-10-29 1990-10-29 Condensed imidazole derivatives and process for preparation thereof
GB909028216A GB9028216D0 (en) 1990-12-31 1990-12-31 Condensed imidazole derivatives and process for preparation thereof
GB919103874A GB9103874D0 (en) 1991-02-25 1991-02-25 Heterocyclic derivatives
GB919106956A GB9106956D0 (en) 1991-04-03 1991-04-03 Heterocyclic derivatives
GB919107231A GB9107231D0 (en) 1991-04-05 1991-04-05 Heterocyclic derivatives
GB919112803A GB9112803D0 (en) 1991-06-14 1991-06-14 Heterocyclic derivatives

Publications (1)

Publication Number Publication Date
PT99038A true PT99038A (pt) 1992-08-31

Family

ID=27562836

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99038A PT99038A (pt) 1990-09-25 1991-09-24 Processo para a preparacao de novos derivados heterociclicos do imidazol e de composicoes farmaceuticas que os contem

Country Status (15)

Country Link
US (1) US5210092A (zh)
EP (1) EP0480204B1 (zh)
JP (1) JPH04288075A (zh)
KR (1) KR920006347A (zh)
CN (1) CN1059723A (zh)
AT (1) ATE135701T1 (zh)
AU (1) AU650473B2 (zh)
CA (1) CA2052125A1 (zh)
DE (1) DE69118082T2 (zh)
FI (1) FI914163A (zh)
HU (1) HUT59404A (zh)
IE (1) IE913164A1 (zh)
IL (1) IL99443A0 (zh)
NO (1) NO913750L (zh)
PT (1) PT99038A (zh)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177074A (en) * 1991-03-26 1993-01-05 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan
TW274551B (zh) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
US5252574A (en) * 1991-04-26 1993-10-12 Merck & Co., Inc. Angiotensin II antagonists incorporating a substituted thiophene or furan
US5198438A (en) * 1991-05-07 1993-03-30 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan
GB9201789D0 (en) * 1992-01-28 1992-03-11 Fujisawa Pharmaceutical Co Heterocyclic derivatives
WO1993019067A1 (en) * 1991-09-12 1993-09-30 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine derivatives as angiotensin ii antagonists
US5354759A (en) * 1991-09-12 1994-10-11 Fujisawa Pharmaceutical Co., Ltd. Angiotenin II antagonizing heterocyclic compounds
US5283242A (en) * 1991-10-24 1994-02-01 American Home Products Corporation Substituted benzimidazoles and quinazolines as antihypertensives
WO1993018030A1 (en) * 1992-03-03 1993-09-16 Fujisawa Pharmaceutical Co., Ltd. Benzimidazole derivatives as angiotensin ii antagonists
US5364869A (en) * 1992-03-09 1994-11-15 Abbott Laboratories Heterocycle-substituted benzyaminopyridine angiotensin II receptor antagonists
EP0577025A3 (de) * 1992-07-01 1998-02-04 Hoechst Aktiengesellschaft Angiotensin-II-Rezeptorantagonisten zur Behandlung und Prophylaxe von koronaren Herzerkrankungen
EP0577023A3 (en) * 1992-07-01 1996-12-18 Hoechst Ag Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
WO1994005633A1 (en) * 1992-09-01 1994-03-17 Ciba-Geigy Ag 3-cyano-4-halogeno-2-(subst.phenyl)-pyrroles as pesticides and fungicides
ATE190613T1 (de) * 1992-10-13 2000-04-15 Searle & Co N-arylheteroarylalkyl-1-phenyl-imidazol-2-on verbindungen bei der behandlung von zirkulatorischen störungen
DE4236026A1 (de) * 1992-10-24 1994-04-28 Merck Patent Gmbh Imidazopyridine
US5376666A (en) * 1992-11-30 1994-12-27 The Du Pont Merck Pharmaceutical Company Angiotension-II receptor blocking, azacycloalkyl or azacycloalkenyl
WO1994013666A1 (en) * 1992-12-07 1994-06-23 Eisai Co., Ltd. Process for producing imidazopyridine derivative and intermediate
US5455260A (en) * 1993-05-21 1995-10-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aliphatic amino bis-aryl squalene synthase inhibitors
US5338740A (en) * 1993-07-13 1994-08-16 Pfizer Inc. Angiotensin II receptor antagonists
NZ309151A (en) * 1995-06-07 2000-01-28 Nippon Shinyaku Co Ltd a 3-substituted cyano or carbamoyl pyrrole derivative and pharmaceutical composition
US6143743A (en) 1997-07-03 2000-11-07 Dupont Pharmaceuticals Company Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
US6124463A (en) * 1998-07-02 2000-09-26 Dupont Pharmaceuticals Benzimidazoles as corticotropin release factor antagonists
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
EP1771169A1 (en) 2004-07-14 2007-04-11 PTC Therapeutics, Inc. Methods for treating hepatitis c
NZ553329A (en) 2004-07-22 2010-09-30 Ptc Therapeutics Inc Thienopyridines for treating hepatitis C
US7531560B2 (en) * 2004-11-10 2009-05-12 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds
PE20070182A1 (es) * 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
PE20070341A1 (es) * 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AR072297A1 (es) 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US8703776B2 (en) 2011-06-15 2014-04-22 Cymabay Therapeutics, Inc. Agonists of GPR131 and uses thereof
US9593109B2 (en) 2011-08-26 2017-03-14 Cymabay Therapeutics, Inc. Bicyclic agonists of GPR131 and uses thereof
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
JP6064062B2 (ja) 2013-03-15 2017-01-18 ファイザー・インク Ampkを活性化させるインダゾール化合物
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
PT3004138T (pt) 2013-06-05 2024-06-18 Bausch Health Ireland Ltd Agonistas ultrapuros de guanilato ciclase c, método de produção e utilização dos mesmos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3130251A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(4-((omega)-(1-imidazolyl)-alkyl)-phenyl)-3-oxo -2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US4916129A (en) * 1989-01-19 1990-04-10 E. I. Du Pont De Nemours And Company Combination β-blocking/angiotensin II blocking antihypertensives
IE64514B1 (en) * 1989-05-23 1995-08-09 Zeneca Ltd Azaindenes
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
TW300219B (zh) * 1991-09-14 1997-03-11 Hoechst Ag

Also Published As

Publication number Publication date
EP0480204B1 (en) 1996-03-20
KR920006347A (ko) 1992-04-27
US5210092A (en) 1993-05-11
EP0480204A1 (en) 1992-04-15
HU913052D0 (en) 1992-01-28
AU650473B2 (en) 1994-06-23
AU8345491A (en) 1992-04-02
CA2052125A1 (en) 1992-03-26
NO913750L (no) 1992-03-26
IL99443A0 (en) 1992-08-18
CN1059723A (zh) 1992-03-25
FI914163A0 (fi) 1991-09-04
DE69118082T2 (de) 1996-10-17
HUT59404A (en) 1992-05-28
DE69118082D1 (de) 1996-04-25
FI914163A (fi) 1992-03-26
NO913750D0 (no) 1991-09-24
JPH04288075A (ja) 1992-10-13
ATE135701T1 (de) 1996-04-15
IE913164A1 (en) 1992-02-25

Similar Documents

Publication Publication Date Title
PT99038A (pt) Processo para a preparacao de novos derivados heterociclicos do imidazol e de composicoes farmaceuticas que os contem
JP5060957B2 (ja) 複素環化合物、その製造方法並びに用途
AU2005316091B2 (en) 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-D]imidazoles as mPGES-1 inhibitors
US5486525A (en) Platelet activating factor antagonists: imidazopyridine indoles
CN101967146B (zh) 作为抗炎与止痛剂的芳基或杂芳基稠合咪唑化合物
FI96025C (fi) Menetelmä angiotensiini II-reseptoreja salpaavien imidatsolien valmistamiseksi
US5124336A (en) Azabenzimidazole derivatives which are thromboxane receptor antagonists
US5338740A (en) Angiotensin II receptor antagonists
US5215994A (en) Angiotenin II antagonizing heterocyclic derivatives
ES2712717T3 (es) Compuesto de difluorometileno
JPH03236377A (ja) 縮合イミダゾール系化合物
CA2482838A1 (en) Pyrazole compounds and pharmaceutical compositions containing the compound
HU195813B (en) Process for preparing 1,2-dihydro-2h-imidazo/4,5-b/quinolin-2-one derivatives i medical compositions containing them as active substance
JPH05504969A (ja) 置換ベンジル要素を含有するアンギオテンシン2アンタゴニスト類
US5250531A (en) Dihydropyrimidine antiallergy agents
JPH11508267A (ja) ピラゾール化合物および医薬組成物
CS991A2 (en) Azaoxindole derivatives and method of their production
JP3439643B2 (ja) ベンゾイミダゾール化合物
FI78089B (fi) Foerfarande foer framstaellning av terapeutiskt verkande imidazo/1,5-a/-pyridinderivat.
WO2000034277A1 (fr) Composes de sulfamide et utilisations de ces derniers en tant que medicaments
US6936632B2 (en) Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
US20210230159A1 (en) 4h-pyrido[1,2-a]pyrimidin-4-one compounds
WO1993019060A1 (en) Isoindazole compound
MXPA01005374A (en) Sulfonamide compounds and uses thereof as medicines

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920408

FC3A Refusal

Effective date: 19981111